Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

G. Masters · SciRah

Researcher profile · Semantic Scholar

G. Masters

Share profile

G. Masters — researcher profile on SciRah

h-index: 48
Works: 161
Citations: 15K

Most-cited papers

Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study
J. Bradley, R. Paulus, R. Komaki, G. Masters +18 more
2015The Lancet Oncology1,708 citations Open access
Semantic Scholar
Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
G. Masters, David H. Johnson, S. Temin
2016Journal of oncology practice / American Society of Clinical Oncology1,363 citations
Semantic Scholar
American Society of Clinical Oncology Clinical Practice Guideline update on chemotherapy for stage IV non-small-cell lung cancer.
C. Azzoli, Sherman Baker, S. Temin, W. Pao +15 more
2009Journal of Clinical Oncology941 citations Open access
Semantic Scholar
Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune checkpoint inhibitor-related adverse events
J. Brahmer, Hamzah Abu-Sbeih, P. Ascierto, J. Brufsky +19 more
2021Journal for ImmunoTherapy of Cancer850 citations Open access
Semantic Scholar
Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients
T. Condamine, George A. Dominguez, Je-in Youn, A. Kossenkov +26 more
2016Science immunology716 citations Open access
Semantic Scholar
Fatty acid transporter 2 reprograms neutrophils in cancer
F. Veglia, V. Tyurin, M. Blasi, A. De Leo +21 more
2019Nature555 citations Open access
Semantic Scholar
Clinical Cancer Advances 2013: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
J. Patel, L. Krilov, S. Adams, C. Aghajanian +15 more
2010Journal of Clinical Oncology464 citations
Semantic Scholar
Long-Term Results of NRG Oncology RTOG 0617: Standard- Versus High-Dose Chemoradiotherapy With or Without Cetuximab for Unresectable Stage III Non-Small-Cell Lung Cancer.
J. Bradley, Chen Hu, R. Komaki, G. Masters +16 more
2019Journal of Clinical Oncology403 citations Open access
Semantic Scholar
Sacituzumab Govitecan, a Trop-2-Directed Antibody-Drug Conjugate, for Patients with Epithelial Cancer: Final Safety and Efficacy Results from the Phase 1/2 IMMU-132-01 Basket Trial.
A. Bardia, W. Messersmith, E. Kio, J. Berlin +19 more
2021Annals of Oncology389 citations Open access
Semantic Scholar
Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
G. Masters, S. Temin, C. Azzoli, G. Giaccone +10 more
2015Journal of Clinical Oncology382 citations Open access
Semantic Scholar
CD45 Phosphatase Inhibits STAT3 Transcription Factor Activity in Myeloid Cells and Promotes Tumor-Associated Macrophage Differentiation
Vinit Kumar, P. Cheng, T. Condamine, Sridevi Mony +12 more
2016Immunity362 citations Open access
Semantic Scholar
Gefitinib versus placebo in completely resected non-small-cell lung cancer: results of the NCIC CTG BR19 study.
G. Goss, C. O'Callaghan, I. Lorimer, M. Tsao +16 more
2013Journal of Clinical Oncology330 citations Open access
Semantic Scholar
ER stress regulates myeloid-derived suppressor cell fate through TRAIL-R-mediated apoptosis.
T. Condamine, Vinit Kumar, I. Ramachandran, Je-in Youn +15 more
2014Journal of Clinical Investigation320 citations Open access
Semantic Scholar
Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update.
N. Hanna, B. Schneider, S. Temin, Sherman Baker +19 more
2020Journal of Clinical Oncology296 citations
Semantic Scholar
Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
N. Hanna, David H. Johnson, S. Temin, Sherman Baker +13 more
2017Journal of Clinical Oncology266 citations
Semantic Scholar
Analysis of classical neutrophils and polymorphonuclear myeloid-derived suppressor cells in cancer patients and tumor-bearing mice
F. Veglia, Ayumi Hashimoto, Harsh Dweep, E. Sanseviero +17 more
2021Journal of Experimental Medicine259 citations Open access
Semantic Scholar
2011 Focused Update of 2009 American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer.
C. Azzoli, S. Temin, Timothy B. Aliff, Sherman Baker +15 more
2011Journal of Clinical Oncology255 citations Open access
Semantic Scholar
Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update.
N. Hanna, A. Robinson, S. Temin, Sherman Baker +19 more
2021Journal of Clinical Oncology253 citations Open access
Semantic Scholar
Eicosanoid modulation in advanced lung cancer: cyclooxygenase-2 expression is a positive predictive factor for celecoxib + chemotherapy--Cancer and Leukemia Group B Trial 30203.
M. Edelman, D. Watson, Xiao-Fei Wang, C. Morrison +9 more
2008Journal of Clinical Oncology196 citations Open access
Semantic Scholar
Unique pattern of neutrophil migration and function during tumor progression
Sima Patel, Shuyu Fu, Jerome Mastio, George A. Dominguez +18 more
2018Nature Immunology192 citations Open access
Semantic Scholar
Quality of Life (QOL) Analysis of a Randomized Radiation Dose Escalation Non-Small Cell Lung Cancer (NSCLC) Study: Radiation Therapy Oncology Group (RTOG) Trial 0617
B. Movsas, Chen Hu, J. Sloan, J. Bradley +16 more
2016JAMA Oncology168 citations Open access
Semantic Scholar
Randomized phase II Study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer: CALGB 30103.
C. Rudin, R. Salgia, Xiao-Fei Wang, L. Hodgson +3 more
2008Journal of Clinical Oncology168 citations Open access
Semantic Scholar
Therapy of Advanced Non-Small-Cell Lung Cancer With an SN-38-Anti-Trop-2 Drug Conjugate, Sacituzumab Govitecan.
R. Heist, M. Guarino, G. Masters, W. Purcell +14 more
2017Journal of Clinical Oncology163 citations
Semantic Scholar
Distinct Populations of Immune-Suppressive Macrophages Differentiate from Monocytic Myeloid-Derived Suppressor Cells in Cancer
T. Kwak, Fang Wang, Hui Deng, T. Condamine +18 more
2020Cell Reports157 citations Open access
Semantic Scholar
Therapy of Small Cell Lung Cancer (SCLC) with a Topoisomerase-I–inhibiting Antibody–Drug Conjugate (ADC) Targeting Trop-2, Sacituzumab Govitecan
J. Gray, R. Heist, A. Starodub, D. Camidge +19 more
2017Clinical Cancer Research148 citations Open access
Semantic Scholar
Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study-CALGB 30504 (Alliance).
N. Ready, H. Pang, L. Gu, G. Otterson +8 more
2015Journal of Clinical Oncology141 citations Open access
Semantic Scholar
Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
G. Masters, David H. Johnson, S. Temin
2016Journal of Oncology Practice127 citations
Semantic Scholar
Identification of monocyte-like precursors of granulocytes in cancer as a mechanism for accumulation of PMN-MDSCs
Jerome Mastio, T. Condamine, George A. Dominguez, A. Kossenkov +21 more
2019Journal of Experimental Medicine107 citations Open access
Semantic Scholar
Immune suppressive activity of myeloid-derived suppressor cells in cancer requires inactivation of the type I interferon pathway
Kevin Alicea-Torres, E. Sanseviero, Jun Gui, Jin-Yun Chen +16 more
2021Nature Communications99 citations Open access
Semantic Scholar
Institutional Enrollment and Survival Among NSCLC Patients Receiving Chemoradiation: NRG Oncology Radiation Therapy Oncology Group (RTOG) 0617.
B. Eaton, S. Pugh, J. Bradley, G. Masters +9 more
2016Journal of the National Cancer Institute95 citations Open access
Semantic Scholar
Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Summary.
N. Hanna, David H. Johnson, S. Temin, G. Masters
2017Journal of Oncology Practice94 citations Open access
Semantic Scholar
Clinical cancer advances 2015: Annual report on progress against cancer from the American Society of Clinical Oncology.
G. Masters, L. Krilov, H. Bailey, M. Brose +15 more
2015Journal of Clinical Oncology88 citations Open access
Semantic Scholar
High-Dose Once-Daily Thoracic Radiotherapy in Limited-Stage Small-Cell Lung Cancer: CALGB 30610 (Alliance)/RTOG 0538
J. Bogart, Xiao-Fei Wang, G. Masters, Jun-Heng Gao +10 more
2023Journal of Clinical Oncology87 citations
Semantic Scholar
Safety and Immunogenicity of the PRAME Cancer Immunotherapeutic in Patients with Resected Non–Small Cell Lung Cancer: A Phase I Dose Escalation Study
J. Pujol, T. De Pas, A. Rittmeyer, E. Vallières +15 more
2016Journal of Thoracic Oncology86 citations Open access
Semantic Scholar
Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline
Navneet Singh, S. Temin, Sherman Baker, Elizabeth M. Blanchard +21 more
2022Journal of Clinical Oncology85 citations Open access
Semantic Scholar
Therapy for Stage IV Non–Small-Cell Lung Cancer With Driver Alterations: ASCO Living Guideline
Navneet Singh, S. Temin, Sherman Baker, Elizabeth M. Blanchard +21 more
2022Journal of Clinical Oncology84 citations Open access
Semantic Scholar
Clinical cancer advances 2011: Annual Report on Progress Against Cancer from the American Society of Clinical Oncology.
N. Vogelzang, S. Benowitz, S. Adams, C. Aghajanian +14 more
2012Journal of Clinical Oncology72 citations Open access
Semantic Scholar
A Randomized, Phase III Study of Carboplatin/Paclitaxel or Carboplatin/Paclitaxel/Bevacizumab with or without Concurrent Cetuximab Investigating EGFR FISH in Patients with Advanced Non-Small Cell Lung Cancer: SWOG S0819
R. Herbst, M. Redman, Edward S. Kim, T. Semrad +14 more
2017The Lancet Oncology65 citations Open access
Semantic Scholar
A phase II study of induction chemotherapy followed by thoracic radiotherapy and erlotinib in poor risk stage III non-small cell lung cancer: Results of CALGB 30605 (Alliance)/RTOG 0972 (NRG)
R. Lilenbaum, M. Samuels, Xiao-Fei Wang, F. Kong +7 more
2015Journal of Thoracic Oncology52 citations Open access
Semantic Scholar
Chemotherapy-free treatment with inotuzumab ozogamicin and blinatumomab for older adults with newly diagnosed, Ph-negative, CD22-positive, B-cell acute lymphoblastic leukemia: Alliance A041703.
M. Wieduwilt, Jun Yin, O. Kour, Rebecca Teske +13 more
2023Journal of Clinical Oncology48 citations
Semantic Scholar
Clinical cancer advances 2010: annual report on progress against cancer from the American Society of Clinical Oncology.
M. Kris, S. Benowitz, S. Adams, L. Diller +11 more
2010Journal of Clinical Oncology48 citations Open access
Semantic Scholar
Long-Term Results of RTOG 0617: A Randomized Phase 3 Comparison of Standard Dose Versus High Dose Conformal Chemoradiation Therapy +/- Cetuximab for Stage III NSCLC
Jeffrey D. Bradley, Chen Hu, R. Komaki, G. Masters +15 more
201747 citations
Semantic Scholar
Attention to diet, exercise, and weight in oncology care: Results of an American Society of Clinical Oncology national patient survey
J. Ligibel, L. Pierce, C. Bender, Tracy E. Crane +9 more
2022Cancer41 citations
Semantic Scholar
美国临床肿瘤学会Ⅳ期非小细胞肺癌化疗的临床实践指南更新
C. Azzoli, Sherman Baker, S. Temin, W. Pao +15 more
2010Zhongguo fei ai za zhi = Chinese journal of lung cancer41 citations
Semantic Scholar
Pemetrexed in Second Line and beyond Small Cell Lung Cancer: A Hoosier Oncology Group Phase II Study
S. Jalal, R. Ansari, R. Govindan, S. Bhatia +7 more
2009Journal of Thoracic Oncology34 citations Open access
Semantic Scholar
Phase 3 comparison of high-dose once-daily (QD) thoracic radiotherapy (TRT) with standard twice-daily (BID) TRT in limited stage small cell lung cancer (LSCLC): CALGB 30610 (Alliance)/RTOG 0538.
J. Bogart, Xiao-Fei Wang, G. Masters, Jun-Heng Gao +9 more
202129 citations
Semantic Scholar
Precision Medicine in Lung Cancer Treatment.
D. Shah, G. Masters
2020Surgical Oncology Clinics of North America29 citations
Semantic Scholar
A randomized, double‐blind, phase 2 trial of platinum therapy plus etoposide with or without concurrent vandetanib (ZD6474) in patients with previously untreated extensive‐stage small cell lung cancer: Hoosier Cancer Research Network LUN06‐113
R. Sanborn, J. Patel, G. Masters, Nagesh H. Jayaram +5 more
2017Cancer29 citations Open access
Semantic Scholar
An innovative symptom monitoring tool for people with advanced lung cancer: a pilot demonstration.
Kimberly M. Davis, S. Yount, Katie Del Ciello, Margaret M Whalen +7 more
2007The Journal of Supportive Oncology29 citations
Semantic Scholar
Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2022.2
Dwight H. Owen, Navneet Singh, Nofisat Ismaila, Elizabeth M. Blanchard +16 more
2022Journal of Clinical Oncology27 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Temin×12
Invite
S. Temin — researcher profile on SciRah
J. Brahmer×10
Invite
J. Brahmer — researcher profile on SciRah
J. Schiller×10
Invite
J. Schiller — researcher profile on SciRah
Sherman Baker×9
Invite
Sherman Baker — researcher profile on SciRah

×9

Invite

D. Gabrilovich — researcher profile on SciRah

David H. Johnson×8

Invite

David H. Johnson — researcher profile on SciRah

Invite

J. Bogart — researcher profile on SciRah

A. Kossenkov×7

Invite

A. Kossenkov — researcher profile on SciRah

Invite

Y. Nefedova — researcher profile on SciRah

N. Hockstein×7

Invite

N. Hockstein — researcher profile on SciRah

Invite

Brian Nam — researcher profile on SciRah

Invite

M. Guarino — researcher profile on SciRah